K Xie, K Sugimoto, M Tanaka, H Akasaka… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Diabetes mellitus is recognized as a risk factor for sarcopenia. Luseogliflozin, a selective
sodium-glucose cotransporter 2 (SGLT2) inhibitor, reduces inflammation and oxidative …